leisure time -WSS

leisure time

author：explore 2025-09-30 20:05:45 - browse：34924

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Scientific mystery highlights the blind spots in genomics databases

WSS

Overprescribed: High cost isn't America's only drug problem

When waiting feels immoral: Empathy in the emergency department

Personalized medicine goes far beyond genetics

Physicians aren't 'burning out.' They're suffering from moral injury

Medicare Advantage 2025 payments will dip, Biden administration says

How I helped Pfizer think through the ethics of Viagra

leisure time

leisure time

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Pancreatic cancer is often deadly, but new discoveries are raising hope

Wildfire smoke exposes gaps in outdoor worker protections

Overprescribed: High cost isn't America's only drug problem

Heart attack and stroke risk calculators need revising

Harvard scientists, with Google, unveil the most detailed brain map ever

Hollywood unions extend contract negotiations for actors

Oral obesity drug from Viking Therapeutics hits key early target

United colonoscopy coverage change 'may cost lives,' doctors say

How to ethically and practically extend health care to all

Wikipedia

FDA approves Sage Therapeutics’ rapid

Personalized medicine goes far beyond genetics

Alzheimer's risk factor APOE4 may be a distinct form of the disease

2 officers injured in shooting in Orlando, police say

Insurer loopholes limit power of law against surprise medical bills

Scientific mystery highlights the blind spots in genomics databases

Wikipedia

focus

focus

knowledge